Piromelatine (Neu-P11)
Piromelatine PSG-RBD
Phase 2 small_molecule active
Quick answer
Piromelatine (Neu-P11) for idiopathic (isolated) Rapid Eye Movement Behavior Disorder is a Phase 2 program (small_molecule) at Lacuna Pharma Pty Ltd with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Lacuna Pharma Pty Ltd
- Indication
- idiopathic (isolated) Rapid Eye Movement Behavior Disorder
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active